| VPZ | PPI | p value | |
| No. of patients enrolled | 1053 | 1053 | |
| Completed the therapy | 1044 | 1049 | |
| Age (Years) | 58.9 ± 10.8 | 59.0 ± 10.7 | 0.843 |
| Gender | 0.459 | ||
| Male | 531 | 514 | |
| Female | 522 | 539 | |
| BMI (kg/m2) | 22.7 ± 3.0 | 22.6 ± 3.0 | 0.399 |
| Endoscopic findings | 0.730 | ||
| No abnormality | 4 | 3 | |
| Duodenal ulcer | 8 | 8 | |
| Atrophic gastritis | 1012 | 1017 | |
| Gastric ulcer | 29 | 25 | |
| Smoking (yes) | 126 | 129 | 0.841 |
| Drinking (yes) | 490 | 505 | 0.513 |
| Logic of the propensity score | −0.49 ± 0.28 | −0.49 ± 0.28 | 0.997 |
| Successful eradication | 961 | 836 |
|
| ITT analysis* % (95% CI) | 91.3 (89.4 - 92.8) | 79.4 (76.8 - 81.7) | <.0001 |
| PP analysis % (95% CI) | 92.1 (90.3 - 93.5) | 79.7 (77.2 - 82.0) | <.0001 |
| Adverse events | 46 | 45 | 0.915 |